Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;619(7969):410-419.
doi: 10.1038/s41586-023-06175-5. Epub 2023 May 17.

EMC chaperone-CaV structure reveals an ion channel assembly intermediate

Affiliations

EMC chaperone-CaV structure reveals an ion channel assembly intermediate

Zhou Chen et al. Nature. 2023 Jul.

Abstract

Voltage-gated ion channels (VGICs) comprise multiple structural units, the assembly of which is required for function1,2. Structural understanding of how VGIC subunits assemble and whether chaperone proteins are required is lacking. High-voltage-activated calcium channels (CaVs)3,4 are paradigmatic multisubunit VGICs whose function and trafficking are powerfully shaped by interactions between pore-forming CaV1 or CaV2 CaVα1 (ref. 3), and the auxiliary CaVβ5 and CaVα2δ subunits6,7. Here we present cryo-electron microscopy structures of human brain and cardiac CaV1.2 bound with CaVβ3 to a chaperone-the endoplasmic reticulum membrane protein complex (EMC)8,9-and of the assembled CaV1.2-CaVβ3-CaVα2δ-1 channel. These structures provide a view of an EMC-client complex and define EMC sites-the transmembrane (TM) and cytoplasmic (Cyto) docks; interaction between these sites and the client channel causes partial extraction of a pore subunit and splays open the CaVα2δ-interaction site. The structures identify the CaVα2δ-binding site for gabapentinoid anti-pain and anti-anxiety drugs6, show that EMC and CaVα2δ interactions with the channel are mutually exclusive, and indicate that EMC-to-CaVα2δ hand-off involves a divalent ion-dependent step and CaV1.2 element ordering. Disruption of the EMC-CaV complex compromises CaV function, suggesting that the EMC functions as a channel holdase that facilitates channel assembly. Together, the structures reveal a CaV assembly intermediate and EMC client-binding sites that could have wide-ranging implications for the biogenesis of VGICs and other membrane proteins.

PubMed Disclaimer

Figures

Extended Data Fig. 1 |
Extended Data Fig. 1 |. EMC:CaV1.2(ΔC)/CaVβ3 and CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 Cryo-EM analysis.
a-d, Exemplars of purified CaV1.2(ΔC)/CaVβ3: a, SEC (Superose 6 Increase 10/300 GL). b, peak fraction SDS-PAGE. c, electron micrograph (~105,000x magnification), and d, 2D class averages. eh Exemplars of purified CaV1.2(ΔC)/CaVβ3/CaVα2δ-1: e, SEC (Superose 6 Increase 10/300 GL). f, peak fraction SDS-PAGE. Magenta bars in ‘a’ and ‘e’ mark peak fraction. g, electron micrographs (~105,000x magnification), and h, 2D class averages. i, Workflow for electron microscopy data processing for the CaV1.2(ΔC)/CaVβ3 and CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 samples. Initial cryoSPARC-3.2 Ab initio reconstruction identified a population of particles containing the EMC:CaV1.2(ΔC)/CaVβ3 complex in the CaV1.2(ΔC)/CaVβ3 sample and populations of particles containing either the EMC:CaV1.2(ΔC)/CaVβ3 complex or CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 complex in the CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 sample. Red arrows indicate the three classes that were re-extracted, subjected to multiple rounds of 3D heterogeneous classification, and exported from cryoSPARC-3.2 for further 3D refinement in RELION-3.1. This resulted in two maps for the EMC:CaV1.2(ΔC)/CaVβ3 complex (ECAB Maps 1 and 2) and one for the CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 complex (CABAD Map 1). Multibody refinement was performed in RELION-3.1 to improve the features of flexible regions of the three maps. This resulted in the final map for the CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 complex (CABAD Map 2). ECAB Maps 1–2 with improved flexible features were merged (cross correlation = 0.9836) to obtain the final map for the EMC:CaV1.2(ΔC)/CaVβ3 complex (ECAB Map 3). Red boxes indicate the final maps used for model building. For ‘b-c’, N = 3. For ‘f-g’, N = 2.
Extended Data Fig. 2 |
Extended Data Fig. 2 |. Cryo-EM maps of EMC:CaV1.2(ΔC)/CaVβ3 and CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 complexes.
EMC:CaV1.2(ΔC)/CaVβ3 complex a, side views and b, lumenal (left) and cytoplasmic (right) views. Subunits are coloured as: EMC1 (light blue), EMC2 (aquamarine), EMC3 (light magenta), EMC4 (Forest), EMC5 (light pink), EMC6 (white), EMC7 (marine), EMC8 (orange), EMC10 (smudge), CaV1.2 (bright orange), and CaVβ3 (lavender). CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 c, side views and d, extracellular (left) and cytoplasmic (right) views. Subunits are coloured as: CaV1.2 (slate), CaVβ3 (violet), and CaVα2δ-1 (greencyan). Detergent micelle is clear.
Extended Data Fig. 3 |
Extended Data Fig. 3 |. EMC:CaV1.2(ΔC)/CaVβ3 binding sites.
a, View of the TM dock interaction. EMC1 TM1 (slate) and CaV1.2 VSD I (yellow orange) interface. Interface buries 1051 Å2. Select elements and residues are indicated. EMC1 residues are in italics. b, LigPLOT diagram of EMC1 TM:CaV1.2 VSD I interactions showing ionic interactions (dashed lines) and van der Waals contacts ≤ 5Å. c, Sequence comparison of the indicated VSDI sequences for human CaV1.2 (HsCaV1.2 (109–182)) (Uniprot Q13936–20) with rabbit CaV1.1 (OcCaV1.1 (36–109)) (NCBI: NP_001095190.1), and human L-type (HsCaV1.1 (36–109), HsCaV1.3 (111–184), and HsCaV1.4 (77–150)) (NCBI: NP_000060.2, NP_000711.1, and NP_005174.2) and non-L-Type (HsCaV2.1 (83–156), HsCaV2.2 (80–153), and HsCaV2.3 (74–147)) (NCBI: NP_000059.3, NP_000709.1, and NP_001192222.1) channels. Red asterisks indicate residues involved in the cation-π pocket (120 and 123) and salt bridge (161). Red band highlights the residue that coordinates the Ca2+ ion in the CaVα2δ VWA domain. d, CaVβ3:EMC8 interaction. Callouts show the details of the indicated parts of the CaVβ3 NK loop interaction with EMC8. e, LigPLOT diagram of CaVβ3:EMC8 interactions showing ionic interactions (dashed lines) and van der Waals contacts ≤ 5Å. CaVβ:EMC8 hydrogen bond and salt bridge pairs are: Asp220:His208, Ser222:His208, Arg226:Glu166, Lys234:Thr8, Arg240:Asp56/Tyr87, Ser242:Lys204, and Gln279: His208. f, Sequence conservation for the indicated CaVβ elements from the EMC8 (top) and EMC2 (bottom) interaction sites. OcCaVβ3 (Uniprot P54286; 218–243, 277–282; 300–322); HsCaVβ1 (Uniprot Q02641.3; 270–295, 329–334; 352–374); HsCaVβ2 (Uniprot Q08289; 322–347, 381–386; 404–426); RnCaVβ2 (Uniprot Q8VGC3; 318–343, 377–382; 400–422); HsCaVβ3 (Uniprot P54284; 218–243, 277–282; 300–322); HsCaVβ4 (Uniprot O00305; 260–285, 319–324; 342–364). g, Superposition of rat CaVβ3 alone (violet, PDB:1VYU, chain B) and CaVβ3 from the EMC complex. Boundaries of the disordered part of the T218-A243 loop in CaVβ3, and Q301, and ABP, are indicated, (RMSD = 1.39Å). h, LigPLOT diagram of CaVβ3:EMC2 interactions showing van der Waals contacts ≤ 5Å.
Extended Data Fig. 4 |
Extended Data Fig. 4 |. CaV1.2 structural details.
ad, Structures of the indicated VSDs from the CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 complex. Gating charge residues, anionic counter charges (An1 and An2) and aromatic site of the charge transfer centre,, are shown. e, LigPLOT diagram of the CaVα2δ-1 leucine binding site showing hydrogen bonds and ionic interactions (dashed lines) and van der Waals contacts ≤ 5Å. f, LigPLOT diagram of blocking lipid: CaV1.2 showing van der Waals contacts ≤ 5Å. Domain I (yellow orange), Domain II (dark red), and Domain III (green) residues are indicated.
Extended Data Fig. 5 |
Extended Data Fig. 5 |. Conformational changes between EMC-bound and CaVα2δ-bound CaV1.2(ΔC)/CaVβ3.
Superposition of CaV1.2 from the EMC:CaV1.2(ΔC)/CaVβ3 and CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 complexes showing a, VSD conformational changes. b, PD conformational changes showing the superposition from ‘a’. Insets show each PD. Elements CaV1.2 from the EMC complex are: VSD I/PD I (yellow orange), VSD II/PD II (firebrick), VSD III/PD III (lime), VSD IV/PD IV (marine). CaV1.2 (slate) and CaVβ3 (violet) from CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 and CaVβ3 from the EMC (light teal) are semi-transparent. c, Superposition of CaVβ3 and the CaV1.2 AID helix from the EMC:CaV1.2(ΔC)/CaVβ3 and CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 complexes. Location of EMC8 is indicated by the orange oval. Red arrows in ‘a-c’ indicate conformational changes between CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 and EMC:CaV1.2(ΔC)/CaVβ3. d, Comparison of IIS0 and surrounding regions in the EMC complex (VSDII, firebrick; AID (yellow orange), and CaVβ3 (light teal)) their corresponding elements in CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 (slate). e, Interactions between VSD II:PD III in the CaVβ:AID:VSD II: PD III subcomplex from the EMC:CaV1.2(ΔC)/CaVβ3 structure.
Extended Data Fig. 6 |
Extended Data Fig. 6 |. CaV1.2 pore domain superposition for EMC-bound and CaVα2δ-bound CaV1.2(ΔC)/CaVβ3.
Pore domains from the EMC-bound complex are: PD I (yellow orange), PD II (firebrick), PD III (lime), and PD IV (marine). Pore domains from CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 are slate. Calcium ions are from CaV1.2(ΔC)/CaVβ3/CaVα2δ-1. Selectivity filter (SF), hydrophobic cavity, and inner gate regions and select residues are indicated.
Extended Data Fig. 7 |
Extended Data Fig. 7 |. Mutually exclusive interactions of the EMC holdase and CaVα2δ with the core CaV1.2/CaVβ3 complex and ordering of the CaV1.2 pore and VSDs by CaVα2δ.
a, Superposition of CaVα2δ-1 (semi-transparent, aquamarine) from the CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 structure with the EMC:CaV1.2/CaVβ3 complex. EMC1 surface is shown. Red oval highlights clash regions. Colours of the EMC:CaV1.2/CaVβ3 complex are as in Fig. 1a. Grey bars denote the membrane. b, Close up view of clash between EMC1 (light blue) and CaVα2δ-1 (aquamarine). EMC1, EMC3 (magenta), EMC5 (pink), EMC6 (white), VSD I (yellow orange), PD II (firebrick), and PD III (lime) from the EMC:CaV1.2/CaVβ3 complex are shown. Red oval highlights clash regions. CaVα2δ-1 domains are indicated. Divalent staple is indicated. SF calcium ions are from CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 and mark the location of the pore in the CaVα2δ-assembled channel. c, Superposition of VSD I (yellow orange), PD II (firebrick), and PD III (lime) from the EMC complex (semi-transparent) and their corresponding parts from CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 (slate). CaVα2δ-1 (aquamarine) is shown as a semi-transparent surface. Calcium ions are from CaV1.2(ΔC)/CaVβ3/CaVα2δ-1. Left inset shows the coordination of the divalent staple by the VWA domain MIDAS and D151 in CaV1.2(ΔC)/CaVβ3/CaVα2δ-1. Red distance shows the position of CaV1.2 D151 in the EMC complex relative to the calcium ion in the CaVα2δ complex. Asterisks mark positions where coordinated alanine mutation impair the ability of CaVα2δ to enhance CaV currents and surface expression. Right inset shows the extensive contacts between PD II and PD III loops with CaVα2δ in the CaV1.2(ΔC)/CaVβ3/CaVα2δ-1 complex. The PD III loops are disordered in the EMC:CaV1.2/CaVβ3 complex. CaVα2δ-1 residues are in italics. d, Schematic showing of the conformational changes and interaction sites in the exchange between the EMC:CaV/CaVβ holdase complex and assembled CaV/CaVβ/CaVα2δ channel. Black ovals indicate key interaction sites in each complex.
Extended Data Fig. 8 |
Extended Data Fig. 8 |. Exemplar purification of CaV subunit combinations.
a-c Superose 6 Increase 10/300 GL chromatogram and peak fraction SDS-PAGE for: a, CaV1.2(ΔC)/CaVβ3 and b, CaV1.2(ΔC). c, Relative detection by mass spectrometry from ‘a’ and ‘b’ of EMC proteins with respect to CaV1.2(ΔC) across 3 replicates. d, Superose 6 Increase 10/300 GL chromatogram and peak fraction SDS-PAGE for CaVβ3. CaVβ3-NK and CaVβ3-SH3 are CaVβ3 proteolytic fragments. e, Absolute detection of EMC proteins and CaVβ3 by mass spectrometry following expression and purification of CaVβ3. f, Superose 6 Increase 10/300 GL chromatogram and peak fraction SDS-PAGE for CaV1.2/CaVβ3. Magenta bars in ‘a’ ‘b’, ‘d’, and ‘f’ mark peak fraction. g, Absolute detection of CaV1.2, CaV1.2(ΔC), CaVβ3, and EMC proteins from ‘a’ and ‘f’. Error bars are calculated as SEM. ND denotes not detected.
Extended Data Fig. 9 |
Extended Data Fig. 9 |. Functional and biochemical characterization of CaV mutants.
a, Voltage dependent activation (left) and I-V relationships (right) for the indicated channels. Parentheses indicate ‘n’ independent cells examined over >2 independent experiments. b, Superose 6 Increase 10/300 GL chromatogram and peak fraction SDS-PAGE for CaV1.2(ΔC)/CaVβ3(11A). Magenta bar marks peak fraction. c, Relative detection by mass spectrometry from ‘b’ of EMC proteins with respect to CaV1.2(ΔC) across 3 replicates. Data for CaV1.2(ΔC)/CaVβ3 are from Extended Data Fig. 8c. ‘ND’ indicates ‘not detected. Data in ‘a’ and ‘c’ are presented as mean ± SEM.
Fig. 1 |
Fig. 1 |. The structure of the EMC–CaV1.2(ΔC)–CaVβ3 complex.
a, Cartoon structure side views of the EMC–CaV1.2(ΔC)–CaVβ3 complex. EMC1, EMC2, EMC3, EMC4, EMC5, EMC6, EMC7, EMC8, EMC10, CaV1.2 and CaVβ3 are shown. EMC subunits are shown with semi-transparent surfaces. The arrows indicate dimensions. b, The location of the TM dock and Cyto dock EMC client-binding sites. CaV1.2 components interacting with the EMC are shown as cylinders. The AID helix is also shown. The grey bars in a and b denote the membrane. c, Lumenal view of the EMC–CaV1.2(ΔC)–CaVβ3 complex transmembrane elements. EMC components are shown as cylinders. CaV1.2(ΔC) domains are coloured as domain I (yellow orange), domain II (dark red), domain III (lime) and domain IV (deep blue). VSD and PD elements are labelled. The red oval in b and c shows the TM dock site. The pale purple circle shows the site of interaction of the EMC1 brace/crossbar helix with CaV1.2 VSD I and PD II (outlined). d, Side view of the TM dock–VSD I interaction. Insets: details of interactions in the of the EMC1 brace/crossbar helix with CaV1.2 VSD I and PD II. f, Details of the Cyto dock. CaVβ and AID helix are shown as cylinders. EMC2, EMC3, EMC4, EMC5, EMC6 and EMC8 are shown as surfaces. Insets: details of the EMC2 and EMC8 sites.
Fig. 2 |
Fig. 2 |. The structure of the CaV1.2(ΔC)–CaVβ3–CaVα2δ-1 channel complex.
a, Side views of CaV1.2(ΔC)–CaVβ3–CaVα2δ-1. Leucine and blocking lipid are shown as space filling. The grey bars denote the membrane. b, Details of the CaVα2δ-1 Cache1 ligand-binding site. Leucine (purple) and contacting side chains from CaVα2δ1 (green cyan) are shown as sticks. c, Details of the blocking-lipid-binding site. CaV1.2 PDs are shown as cylinders and coloured as follows: PD I (yellow orange), PD II (dark red), PD III (lime) and PD IV (deep blue). Lipid-contact residues are shown as sticks. Blocking lipid is shown as space filling (left) and sticks (right). d, Interaction between the blocking lipid and SF ions. Hallmark SF calcium-binding residues are shown as sticks (purple). SF calcium ions are indicated.
Fig. 3 |
Fig. 3 |. EMC interactions remodel CaV structure and extract PD III.
a, Superposition of CaV1.2–CaVβ3 from the EMC and CaV1.2(ΔC)–CaVβ3–CaVα2δ-1 complexes. CaV1.2 elements from the EMC complex are coloured as follows: VSD I/PD I (yellow orange), VSD II/PD II (dark red), VSD III/PD III (lime) and VSD IV/PD IV (deep blue). CaV1.2 (purple) and CaVβ3 (magenta) from CaV1.2(ΔC)–CaVβ3–CaVα2δ and CaVβ3 from the EMC (light teal) are semi-transparent. The red arrows indicate conformational changes between CaV1.2(ΔC)–CaVβ3–CaVα2δ-1 and EMC–CaV1.2(ΔC)–CaVβ. Coloured ovals highlight key domains reshaped by the EMC. b, Superposition of the S4 and S4–S5 linker–PD III elements from the EMC–CaV1.2(ΔC)–CaVβ3 complex (lime) and CaV1.2(ΔC)–CaVβ3–CaVα2δ-1 (purple). The Cα–Cα distance for Val1019 is indicated. c, Interactions within the CaVβ–AID–VSD II–PD III subcomplex in EMC–CaV1.2(ΔC)–CaVβ3. The grey bars in a and c denote the membrane.
Fig. 4 |
Fig. 4 |. EMC association causes CaV1.2 pore structural changes.
a, CaV1.2 pore profile comparison for EMC–CaV1.2(ΔC)–CaVβ3 (orange) and CaV1.2(ΔC)–CaVβ3–CaVα2δ-1 (blue), calculated using HOLE. EMC: SF = 1.78 Å, inner gate = 1.98 Å; CaV1.2: SF = 0.65 Å, inner gate = 0.98 Å. b, Side views of EMC–CaV1.2(ΔC)–CaVβ3 (left) and CaV1.2(ΔC)–CaVβ3–CaVα2δ (right) pore profiles calculated using MOLE. The SF, central cavity and hydrophobic gate regions are indicated. SF and intracellular gate residues are shown. c, Comparison of the CaV1.2 SF filter regions in the EMC–CaV1.2(ΔC)–CaVβ3 pore (PD I, PD II, PD III and PD IV) and CaV1.2(ΔC)–CaVβ3–CaVα2 δ-1 (semi-transparent, purple). Ca2+−1 from CaV1.2(ΔC)–CaVβ3–CaVα2δ-1 is shown as a white sphere. d,e, View of the CaV1.2 intracellular gate from EMC–CaV1.2(ΔC)–CaVβ3 (d) and CaV1.2(ΔC)–CaVβ3–CaVα2δ-1 (e). GDN is shown as sticks. PDs are coloured as follows: PD I (yellow orange), PD II (dark red), PD III (lime) and PD IV (deep blue). f,g, Side views of the EMC–CaV1.2(ΔC)–CaVβ3 pore showing global (f) and detailed (g) views. SF glutamates in e and GDN-contacting residues in f are shown as sticks. PD elements are labelled.
Fig. 5 |
Fig. 5 |. Disruption of EMC–channel interactions affects CaV function.
a,b, Cartoon diagrams showing the location of TM dock 3A mutants (a), and Cyto dock 5A (magenta), Δ220–240 (red) and 11A (sticks) mutants (b). c, Current densities at +20 mV for the indicated channels and HEK293FT cell lines. Data are mean ± s.e.m. The values in parentheses indicate n independent cells examined over ≥2 independent experiments. Statistical significance was assessed using two-sided unpaired t-tests between Cav1.2(ΔC)–Cavβ3 and mutants. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P = 0.01–0.05; NS, P > 0.05. d, Exemplar Ca2+ currents for HEK293 cells expressing the indicated channels in the presence of CaVα2δ-1. Insets: the stimulation protocol and currents at +20 mV. e, Cartoon of the EMC–CaV1.2(ΔC)–CaVβ3 complex showing the following selected elements: EMC1, EMC2, EMC3, EMC5, EMC6, EMC8, CaV1.2 VSD I and PD II, and CaVβ3. The arrows indicate the TM dock and Cyto dock. Surfaces are shown for EMC5 and EMC6. f, Exemplar CaV1.2(ΔC)–CaVβ3–CaVα2δ-1 Ca2+ currents for HEK293FT and HEK293FT EMC5-knockout and EMC6-knockout cells. Insets: the protocol and currents at +20 mV.

References

    1. Catterall WA, Wisedchaisri G & Zheng N The chemical basis for electrical signaling. Nat. Chem. Biol. 13, 455–463 (2017). - PMC - PubMed
    1. Isacoff EY, Jan LY & Minor DL Jr. Conduits of life’s spark: a perspective on ion channel research since the birth of neuron. Neuron 80, 658–674 (2013). - PMC - PubMed
    1. Zamponi GW, Striessnig J, Koschak A & Dolphin AC The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol. Rev. 67, 821–870 (2015). - PMC - PubMed
    1. Nanou E & Catterall WA Calcium channels, synaptic plasticity, and neuropsychiatric disease. Neuron 98, 466–481 (2018). - PubMed
    1. Buraei Z & Yang J The β subunit of voltage-gated Ca2+ channels. Physiol. Rev. 90, 1461–1506 (2010). - PMC - PubMed

Publication types

MeSH terms